Gene Query: TPRA1

Dataset Description Geneva Score
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 38.89
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 37.04
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 34.42
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 32.8
FOXD3 is a novel tumor suppressor in lung cancer 30.67
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 30.16
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 25.45
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 20.24
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 19.84
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 17.59
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 16.7
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 16.67
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 16.67
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 16.62
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 16.54
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 16.2
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 15.73
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 15.62
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 15.62
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 15.55
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 14.66
Genome wide expression change by RNF168 knocking down in NEC cells 14.46
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 14.03
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 13.65
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 13.48
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 13.38
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 13.03
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 13.0
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 12.96
Transcriptome analysis in Neobractatin treated cells 12.91
Identification of transcription start sites for human A549 cell line using ReCappable-seq 12.86
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 12.43
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 12.1
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 11.86
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 11.64
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 11.57
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 11.14
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 11.12
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 11.12
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 11.05
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 10.67
snRNAs as regulators of alternative splicing 10.63
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 10.4
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 10.07
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 9.8
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 9.52
hnRNP C is a key regulator of protein synthesis in mitosis 9.5
ZIKV infection of monocytes activates inflammasome pathways 9.46
Characterization of parental and rociletinib-resistant derived H1975 cell lines 9.3
HNF1 regulates critical functions of the human epididymis epithelium. 9.24
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 9.24
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 9.23
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 9.23
RNA-seq analyisis of PUM2 knockout cells 9.18
Pharmacologic inhibition of STAT5 in AML 9.13
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 9.04
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 9.04
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 8.96
RNA sequencing of GlyH-101-treated MCF-7 cell line 8.64
U1 snRNP telescripting regulates size-function stratified human genome 8.62
Gene expression changes after LOC550643 silencing 8.09
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 8.04
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 7.94
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 7.94
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 7.9
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 7.9
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 7.84
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 7.82
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 7.81
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 7.79
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 7.79
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 7.75
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 7.62
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 7.55
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 7.52
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 7.51
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 7.47
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 7.41
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 7.41
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 7.38
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 7.31
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 7.27
A549 cells and MSR-A549 cells 7.25
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 7.25
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 7.21
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 7.21
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 7.16
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 6.86
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 6.86
STRIPAK directs PP2A activity to promote oncogenic transformation 6.86
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 6.67
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 6.63
Transcription elongation regulates genome 3D structure 6.58
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 6.54
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 6.41
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 6.41
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 6.41
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 6.41
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 6.32
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 6.3
Effect of ILF3 on translation during homeostasis and the antiviral response 6.29
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 6.26
EWSR1 influences alternative splicing through direct and indirect mechanisms 6.24
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 6.23
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 6.21
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 6.16
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 6.13
Ebola virus (EBOV) infection of ARPE-19 cells 6.11
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 6.08
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 6.08
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 6.08
Microprocessor mediates transcription termination in long noncoding microRNA genes 6.08
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 6.03
Irf9 function in immunity in mouse 6.03
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 6.0
Primary human trophoblast from term placenta 5.96
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 5.96
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 5.93
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 5.91
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 5.91
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 5.91
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 5.9
Genome-wide functional assessment of enhancer activities in the human genome 5.89
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 5.86
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 5.84
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 5.82
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 5.7
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 5.68
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 5.68
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 5.67
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 5.65
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 5.65
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 5.64
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 5.64
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 5.63
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 5.62
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 5.59
RNA-seq of cells with TET1 knockout 5.59
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 5.55
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 5.53
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 5.48
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 5.46
AR-independent prostate cancer is sustained through FGF signaling 5.45
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 5.44
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 5.39
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 5.38
Illumina Total RNA-seq in HeLa 5.34
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 5.33
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 5.32
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 5.32
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 5.3
Regulation of protein translation during mitosis 5.24
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 5.21
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 5.18
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 5.17
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 5.12
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 5.12
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 5.11
A transcriptome dataset revealing the molecular features of breast cancer stem cells 5.09
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 5.05
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 5.03
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 5.03
m6A-dependent regulation of messenger RNA stability 4.97
Genes significantly down or Up-regulated upon RNF219 knockdown 4.97
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 4.95
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 4.92
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 4.92
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 4.84
TGF-β promotes genomic instability after loss of RUNX3 4.76
CHD1 regulates cell fate determination by activation of differentiation-induced genes 4.76
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 4.73
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 4.7
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 4.66
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 4.66
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 4.62
Transcriptome of Stabilin-1 siRNA transfected human monocytes 4.6
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 4.59
Effect of mitochondria deficiency on senescence-associated gene expression 4.56
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 4.56
Small-molecule targeting of brachyury transcription factor addiction in chordoma 4.52
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 4.52
KLF6-dependent transcription in renal cancer cells 4.49
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 4.46
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 4.44
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 4.43
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 4.43
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 4.42
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 4.42
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 4.38
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 4.37
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 4.37
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 4.37
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 4.31
RNA m5C Methylation in breast cancer using MeRIP-Seq 4.28
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 4.28
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 4.25
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 4.21
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 4.21
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 4.2
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 4.16
RNA-seq differential expression studies: more sequence, or more replication? 4.15
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 4.15
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 4.15
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 4.14
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 4.14
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 4.1
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 4.1
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 4.08
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 4.07
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 4.05
IRF1 regulates IFN dependent and independent gene expression 4.03
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 4.01
ADAR1-editing of cellular and measles virus-derived duplex RNA 4.01
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 4.01
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 4.0
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 4.0
RNA-seq of naive and primed ES cells 3.99
Genome-wide chromatin analysis of Ewing sarcoma 3.98
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 3.98
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 3.96
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 3.94
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 3.94
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 3.89
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 3.89
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 3.89
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 3.89
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 3.87
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 3.87
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 3.86
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 3.86
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 3.86
Paxillin regulates genomic networks in prostate cancer [LNCaP] 3.85
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 3.82
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 3.82
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 3.82
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 3.81
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 3.79
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 3.74
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 3.74
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 3.74
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 3.74
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 3.73
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 3.7
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 3.69
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 3.69
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 3.69
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 3.69
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 3.68
Cajal bodies are linked to genome conformation [RNA-Seq] 3.68
Cajal bodies are linked to genome conformation 3.68
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 3.67
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 3.67
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 3.67
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 3.63
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 3.61
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 3.61
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 3.6
NR2F2 study 3.6
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 3.59
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 3.58
Identification of Nrf2 regulated genes by RNA sequencing 3.57
Nrf2 regulated genes in A549 cells 3.57
Effect of drugs on transcriptomic profiles 3.56
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 3.56
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 3.55
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 3.55
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 3.54
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  3.53
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 3.52
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 3.52
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 3.51
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 3.51
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 3.48
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 3.47
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 3.46
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 3.46
Tpl-2 and MEK small molecule inhibitors 3.44
Tpl-2 small molecule project 3.44
Uridylation by TUT4 and TUT7 marks mRNA for degradation 3.44
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 3.42
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 3.42
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 3.41
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 3.4
Regulation of poly(A) tail and translation during the somatic cell cycle 3.39
Identification of HOXB13 target genes responsive to BET inhibitors 3.38
Downregulation of LATS kinases alters p53 to promote cell migration 3.36
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 3.36
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 3.33
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 3.32
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 3.29
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 3.28
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 3.25
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 3.23
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 3.21
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 3.2
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 3.19
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 3.13
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 3.11
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 3.1
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 3.07
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 3.07
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 3.03
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 3.03
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 3.03
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 3.01
Efficient derivation of microglia-like cells from human pluripotent stem cells 2.96
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 2.96
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 2.96
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 2.88
Sensing self and nonself circular RNAs 2.87
Transcriptome analysis of peripheral blood monocytes 2.87
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 2.86
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 2.86
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 2.86
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 2.85
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 2.84
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 2.83
Paxillin regulates genomic networks in prostate cancer [PC3] 2.83
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 2.79
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 2.77
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 2.74
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 2.71
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 2.69
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 2.68
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 2.65
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 2.64
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 2.62
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 2.62
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 2.58
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 2.58
Gene expression in GBM with Cav3.2 inhibition 2.53
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 2.52
A549 cell transcriptome responses to infection with H7N9 influenza virus 2.52
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 2.52
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 2.5
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 2.5
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 2.49
Expression profiling of MCF-7 cells with treatment of TCDD 2.49
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 2.49
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 2.47
RNA-seq analysis of differentiating human erythroblasts 2.45
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 2.43
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 2.42
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 2.42
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 2.41
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 2.39
Discovering human diabetes-risk gene function with genetics and physiological assays 2.38
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 2.38
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 2.35
Macrophage Ad5f35 M2 Challenge 2.33
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 2.28
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 2.28
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 2.27
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 2.27
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 2.27
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 2.17
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 2.17
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 2.15
RNAseq data from Mesenchymal stem cells treated with TCDD or 1-methyl tryptophan 2.14
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 2.13
Regulation of hypoxia-inducible factor activity by ZMYND8 2.1
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 2.09
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 2.09
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 2.08
Effect of nuclear IL-33 on gene expression 2.04
Measure transcript integrity using RNA-seq data 2.03
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 2.0
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 1.99
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 1.96
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 1.96
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 1.95
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 1.92
Aneuploidy-induced cellular stresses limit autophagic degradation. 1.91
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 1.9
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 1.86
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 1.86
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 1.84
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 1.84
Gene Expression Profiling of WT and KDM3A Knocked out Cell 1.84
mRNA recovered upon RNF219 IP. [RNA-IP] 1.8
MRTF activates TEAD-YAP target gene expression 1.78
DAOY-Notch1/Notch2 knockout: transcriptome comparison 1.78
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 1.77
Transciptomic profiling of human fetal lung samples 1.76
RNA sequencing of human mammary epithelial cells 1.75
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 1.73
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 1.68
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 1.66
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 1.66
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 1.66
RNAseq of cell lines with knocked in ESR1 mutations 1.65
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 1.64
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 1.62
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 1.61
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 1.56
Expression profiling of converted and control dermal BJ fibroblasts 1.56
p63 controls the enhancer landscape during keratinocyte differentiation 1.56
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.51
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 1.48
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 1.48
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 1.43
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 1.43
LIN28A Over-expression RNAseq 1.42
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 1.42
H1609088 Human RNA-Sequencing 1.41
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 1.37
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 1.37
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 1.37
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 1.34
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 1.29
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 1.29
Positively selected enhancer elements endow tumor cells with metastatic competence 1.27
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 1.25
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 1.23
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 1.21
RNA-Seq of PRMT1 overexpression ECA109 cells 1.15
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 1.12
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 1.12
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 1.1
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 1.09
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 1.06
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 1.06
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 1.05
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 1.03
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 1.02
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 1.01
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 1.01
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 0.96
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 0.95
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 0.95
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 0.95
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 0.95
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 0.94
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 0.91
NAPRT activation of macrophages 0.9
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 0.9
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 0.86
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 0.85
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 0.83
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 0.83
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 0.82
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 0.81
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.8
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.8
Exploring ILF2 regulatory genes by next-generation sequencing 0.79
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 0.78
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 0.77
The circadian transcriptional landscape in primary human mammary epithelial cells 0.75
miRNAs affected by antagomiR-17 treatment 0.75
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 0.74
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.73
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.73
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 0.71
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 0.71
MARCKS and lnc-MARCKS act as inflammation regulators 0.69
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 0.68
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 0.68
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 0.65
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 0.64
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 0.64
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 0.63
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 0.62
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 0.61
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.6
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 0.52
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 0.49
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 0.44
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.43
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 0.42
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 0.4
MAIT cell RNA sequencing 0.38
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 0.36
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 0.36
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.35
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 0.3
Ribosome profiling upon inhibition of eIF4A 0.29
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.28
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 0.28
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 0.27
4sUDRB-seq: measuring transcription elongation and initiation genomewide 0.26
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 0.24
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 0.24
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 0.24
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 0.22
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.17
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.12
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.12
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 0.11
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.11
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 0.08
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 0.08
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 0.08
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.08
Enhancer activation during EGF response 0.08
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.06
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.06
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.06
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.06
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.05
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation